WO2001072739A1 - Method for preparing 3-(4-hydroxy-1h-indol-5-ylmethyl)-pyridinium compounds via enones - Google Patents
Method for preparing 3-(4-hydroxy-1h-indol-5-ylmethyl)-pyridinium compounds via enones Download PDFInfo
- Publication number
- WO2001072739A1 WO2001072739A1 PCT/FR2001/000778 FR0100778W WO0172739A1 WO 2001072739 A1 WO2001072739 A1 WO 2001072739A1 FR 0100778 W FR0100778 W FR 0100778W WO 0172739 A1 WO0172739 A1 WO 0172739A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- radical
- alkyl
- formula
- methyl
- indol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 0 *C(Cc1c2c(*)c(*)[n]1*)CC2=O Chemical compound *C(Cc1c2c(*)c(*)[n]1*)CC2=O 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Definitions
- the present invention relates to a new process for the preparation of 3- (4- hydroxy-1 H-indol-5-ylmethyl) -py ⁇ d ⁇ n ⁇ ums compounds of formula (I) via enones
- 3- (4-hydroxy-1 H-indol-5-ylmethyl) -py ⁇ d ⁇ n ⁇ ums are known raw materials used in the dye industry.
- 3- (4-hydroxy-1- methylsulfate) met yl-1 H-indol-5-ylmethyl) -1-methyl-py ⁇ d ⁇ n ⁇ um can be used as coupler in compositions for the oxidation dyeing of keratin fibers, see patent application FR-A-2 783 520
- the compound (C) thus obtained is then quaternized by an alkyl radical, according to the conventional methods of quaternization of pyridines, to lead to a 3- (4-hydroxy-1-alkyl-1 H-indol-5-ylmethyl) -1-alkyl-pyridinium of formula (D).
- the yield indicated in this European patent application for the first step is 9% when the alkyl radical of the compound (A) is methyl. This very low yield during the first stage results in an overall yield of the order of approximately 9%.
- this first step preferably uses potassium tert-butoxide as a base, however this compound involves laborious handling conditions. On the other hand, this process requires high temperature conditions. Finally, acidification, often exothermic, followed by purification by chromatography, is compulsory in order to arrive at the expected compound (C). Therefore, this process is not transferable from an industrial point of view, and a more efficient synthesis method is desirable.
- the present invention therefore relates to a new process for the synthesis of 3- (4-hydroxy-1H-indol-5-ylmethyl) -pyridiniums of formula (I) below:
- - R T represents a hydrogen atom; a CC 6 alkyl radical; a C 7 -C 12 aralkyl radical, a CC 6 monohydroxyalkyl radical; a C 2 -C 6 polyhydroxyalkyl radical; alkoxy (CC 6) alkyl, CC 6; a CC 6 hydroxyalkoxy (C r C 6 ) alkyl radical; a CC amino aminoalkyl radical; a C r C 6 aminoalkyl radical in which the amine is mono or disubstituted by a C r C 6 alkyl radical, by an acetyl radical, by a CC 6 monohydroxyalkyl radical or by a C 2 -C 6 polyhydroxyalkyl radical; an alkyl (C r -C 6) thioalkyl, C r C 6, a monohydroxy radical (CC 6) thioalky e CC 6!; a polyhydroxyalkyl radical (C 2 -C 6)
- R 2 and R 3 identical or different, represent a hydrogen or halogen atom; a CC 6 alkyl radical; a C 7 -C 12 aralkyl radical or a CC 6 alkoxy radical;
- R 4 represents a hydrogen or halogen atom; a hydroxyl radical; an alkyl radical in; a C 7 -C 12 aralkyl radical; a monohydroxyalkyl radical ; a C 2 -C 6 polyhydroxyalkyl radical; a nitro radical; a cyano radical; a C r C 6 cyanoalkyl radical; a C 1 -C 6 alkoxy radical; a trialkyl radical (C r C 6) alkylsilane C r C 6; an amido radical; a carboxyl radical; a C 1 -C 6 alkylcarbonyl radical; a thio radical; a CC 6 thioalkyl radical; an alkyl radical (CC 6 ) thio; an amino radical; an amino radical protected by an alkyl (CC 6 ) carbonyl, carbamyl or alkyl (C., - C 5 ) sulfonyl radical; or an NHR "or NR"
- R 5 represents a C r C 6 alkyl radical; a C r C 6 monohydroxyalkyl radical; a C 2 -C 6 polyhydroxyalkyl radical; a C 7 -C 12 aralkyl radical; a aryl radical; an aminoalkyl radical into a CC 6 aminoalkyl radical, the amine of which is protected by a (C 1 -C 6 ) alkyl carbonyl radical.
- R 6 represents a hydrogen or halogen atom; a CC 6 alkyl radical; a C 1 -C 6 alkoxy radical; an acetylamino radical; a CC 6 monohydroxyalkyl radical; a C 2 -C 6 polyhydroxyalkyl radical; alkoxy (CC 6) C r C 6; a thiophene radical; a furan radical; a phenyl radical; or a CC 6 aralkyl radical;
- - X represents a monovalent or divalent anion
- R 1 and R 5 independently of one another, preferably represent a methyl, ethyl or 2-hydroxyethyl radical;
- R 2 , R 3 , R 4 and R 6 preferably represent a hydrogen atom or a methyl radical.
- X " is preferably chosen from a halogen atom such as chlorine, bromine or iodine; a hydroxide; a hydrogen sulphate; an alkyl sulphate or a carboxylate.
- the solvent or solvents used in the various stages of the process according to the invention are inert solvents such as, for example, a lower C r C 4 alcohol such as methanol, ethanol, isopropanol or isobutanol; ethyl ether; tert-butyl methyl ether; tetrahydrofuran; toluene; hexane; heptane; ethyl acetate; chloroform; dichloromethane or acetonitrile; in the presence or absence of a phase transfer agent such as for example a quaternary ammonium or a salt of sulfosuccinic acid.
- the solvent used is a CC 4 alcohol such as methanol, ethanol, isobutanol; tetrahydrofuran or ethyl acetate.
- the solvent used during the first step is preferably chosen from methanol, ethanol, tetrahydrofuran and toluene.
- the solvent used during the second step is preferably chosen from ethyl acetate and tetrahydrofuran.
- the solvent used during the third step is preferably chosen from ethanol, isopropanol and isobutanol.
- the base used during the first step is preferably chosen from sodium hydroxide, potassium hydroxide, and sodium methylate.
- the amount of base used is preferably of the order of two molar equivalents relative to the number of moles of compound of formula (II) to be reacted.
- the base used during the third step is preferably chosen from triethylamine and piperidine.
- the amount of base used is preferably of the order of two and a half equivalents relative to the number of moles of compound of formula (V) to be reacted.
- the quaternizing agent used during the second step is preferably chosen from dimethyl sulphate and chloromethane.
- the reaction temperature during the first step is between 0 and 60 ° C approximately and preferably between 20 and 30 ° C approximately.
- a particularly preferred temperature is around 25 ° C.
- the expected products such as for example 3- (4-hydroxy-1-methyl-1H-indol-5-ylmethyl) -1-methyl-pyridinium methyl sulfate, may, if necessary, be recovered by methods well known in the state of the art such as filtration or crystallization.
- the compounds of formula (I) obtained according to the process in accordance with the invention can be used as finished products in any type of industry such as the cosmetic industry, in particular as a coupler for the oxidation dyeing of keratin fibers.
- Step 1 Preparation of 1-methyl-5-pyridin-3-ylmethylene-1, 5,6,7- tetrahvdro-indol-4-one
- Step 2 Preparation of 1-methyl-3- (1-methyl-4-oxo-1, 4,6,7-tetrahvdro-indol-5-ylidenemethyl) -pyridinium methyl sulfate
- Step 3 Preparation of 3- (4-hvdroxy-1-methyl-1 H-indol-5-ylmethyl) -1-methyl-pyridinium methyl sulfate
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
PROCEDE DE PREPARATION DE COMPOSES 3 - ( 4-HYDR0XY- 1H- IND0L- 5-YLMETHYL ) - PYRIDINIUM EN PASSANT PAR DES ENONESPROCESS FOR THE PREPARATION OF COMPOUNDS 3 - (4-HYDR0XY- 1H- IND0L- 5-YLMETHYL) - PYRIDINIUM PASSING THROUGH ENONES
La présente invention concerne un nouveau procède de préparation de composés 3-(4- hydroxy-1 H-ιndol-5-ylméthyl)-pyπdιnιums de formule (I) en passant par des enonesThe present invention relates to a new process for the preparation of 3- (4- hydroxy-1 H-indol-5-ylmethyl) -pyπdιnιums compounds of formula (I) via enones
Les 3-(4-hydroxy-1 H-ιndol-5-ylméthyl)-pyπdιnιums sont des matières premières connues et utilisées dans l'industrie des colorants A titre d'exemple, le méthylsulfate de 3-(4- hydroxy-1-mét yl-1 H-ιndol-5-ylméthyl)-1-méthyl-pyπdιnιum peut être utilise à titre de coupleur dans des compositions pour la teinture d'oxydation des fibres kératiniques, voir la demande de brevet FR-A-2 783 5203- (4-hydroxy-1 H-indol-5-ylmethyl) -pyπdιnιums are known raw materials used in the dye industry. For example, 3- (4-hydroxy-1- methylsulfate) met yl-1 H-indol-5-ylmethyl) -1-methyl-pyπdιnιum can be used as coupler in compositions for the oxidation dyeing of keratin fibers, see patent application FR-A-2 783 520
La synthèse des 3-(4-hydroxy-1-alkyl-1 H-ιndol-5-ylméthyl)-1-alkyl-pyrιdιnιums se fait en général en plusieurs étapes, selon le schéma reactionnel simplifié figurant ci-apresThe synthesis of 3- (4-hydroxy-1-alkyl-1 H-indol-5-ylmethyl) -1-alkyl-pyrιdιnιums is generally carried out in several stages, according to the simplified reaction scheme given below
consistant dans une première étape à faire réagir un 1-alkyl-1 ,5,6,7-tetrahydro-ιndol-4- one, (composé (A)), avec la 3-pyrιdιnecarboxaldéhyde, (composé (B)), dans un solvant organique tel que par exemple le t-butanol, en présence d'une correspondant à la température de reflux du solvant utilisé, pour obtenir un composé (C), voir notamment le procédé décrit dans la demande de brevet EP 0 377 450. Le composé (C) ainsi obtenu est ensuite quaternisé par un radical alkyle, selon les méthodes classiques de quaternisation des pyridines, pour conduire à un 3-(4-hydroxy-1-alkyl-1 H-indol-5-ylméthyl)-1-alkyl-pyridinium de formule (D).consisting in a first step of reacting a 1-alkyl-1, 5,6,7-tetrahydro-ιndol-4- one, (compound (A)), with 3-pyrιdιnecarboxaldehyde, (compound (B)), in an organic solvent such as, for example, t-butanol, in the presence of a corresponding to the reflux temperature of the solvent used, to obtain a compound (C), see in particular the process described in patent application EP 0 377 450. The compound (C) thus obtained is then quaternized by an alkyl radical, according to the conventional methods of quaternization of pyridines, to lead to a 3- (4-hydroxy-1-alkyl-1 H-indol-5-ylmethyl) -1-alkyl-pyridinium of formula (D).
Le rendement indiqué dans cette demande de brevet européen pour la première étape est de 9% lorsque le radical alkyle du composé (A) est le méthyle. Ce très faible rendement lors de la première étape entraîne un rendement global de l'ordre d'environ 9 %. De plus cette première étape utilise préférentiellement le tert-butylate de potassium à titre de base, cependant ce composé implique des conditions laborieuses de manipulation. D'autre part, ce procédé nécessite des conditions de température élevées. Enfin, une acidification souvent exothermique, suivie d'une purification par chromatographie, est obligatoire pour aboutir au composé (C) attendu. Par conséquent, ce procédé n'est pas transposable d'un point de vue industriel, et une méthode de synthèse plus efficace est désirable.The yield indicated in this European patent application for the first step is 9% when the alkyl radical of the compound (A) is methyl. This very low yield during the first stage results in an overall yield of the order of approximately 9%. In addition, this first step preferably uses potassium tert-butoxide as a base, however this compound involves laborious handling conditions. On the other hand, this process requires high temperature conditions. Finally, acidification, often exothermic, followed by purification by chromatography, is compulsory in order to arrive at the expected compound (C). Therefore, this process is not transferable from an industrial point of view, and a more efficient synthesis method is desirable.
C'est en cherchant à remédier à ces problèmes que la demanderesse a découvert le procédé objet de l'invention.It is by seeking to remedy these problems that the Applicant discovered the process which is the subject of the invention.
La présente invention a donc pour objet un nouveau procédé de synthèse de 3-(4-hydroxy-1H-indol-5-ylméthyl)-pyridiniums de formule (I) suivante :The present invention therefore relates to a new process for the synthesis of 3- (4-hydroxy-1H-indol-5-ylmethyl) -pyridiniums of formula (I) below:
dans laquelle : - RT représente un atome d'hydrogène ; un radical alkyle en C C6 ; un radical aralkyle en C7-C12, un radical monohydroxyalkyle en C C6 ; un radical polyhydroxyalkyle en C2-C6 ; un radical alcoxy(C C6)alkyle en C C6 ; un radical hydroxyalcoxy(CrC6)alkyle en C C6 ; un radical aminoalkyle en C Cδ ; un radical aminoalkyle en CrC6 dont l'aminé est mono ou disubstituée par un radical alkyle en CrC6, par un radical acétyle, par un radical monohydroxyalkyle en C C6 ou par un radical polyhydroxyalkyle en C2-C6 ; un radical alkyl(Cr C6)thioalkyle en CrC6, un radical monohydroxyalkyl(C C6)thioalky!e en C C6 ; un radical polyhydroxyalkyl(C2-C6)thioalkyle en C,-C6 ; un radical carboxyalkyle en C C6 ; un radical alcoxy(C1-C5)carbonylalkyle en CrC6, un radical acétylaminoalkyle en ; un radical cyanoalkyle en CrC6 ; un radical trifluoroalkyle en C C6 ; un radical halogénoalkyle en CrC5 ; un radical phosphoalkyle en CrC6 ou un radical sulfoalkyle en C C6 ; in which : - R T represents a hydrogen atom; a CC 6 alkyl radical; a C 7 -C 12 aralkyl radical, a CC 6 monohydroxyalkyl radical; a C 2 -C 6 polyhydroxyalkyl radical; alkoxy (CC 6) alkyl, CC 6; a CC 6 hydroxyalkoxy (C r C 6 ) alkyl radical; a CC amino aminoalkyl radical; a C r C 6 aminoalkyl radical in which the amine is mono or disubstituted by a C r C 6 alkyl radical, by an acetyl radical, by a CC 6 monohydroxyalkyl radical or by a C 2 -C 6 polyhydroxyalkyl radical; an alkyl (C r -C 6) thioalkyl, C r C 6, a monohydroxy radical (CC 6) thioalky e CC 6!; a polyhydroxyalkyl radical (C 2 -C 6) thioalkyl, C, -C 6 alkyl; a CC 6 carboxyalkyl radical; alkoxy (C 1 -C 5) alkoxycarbonyl C r C 6, a acetylaminoalkyl radical ; a C r C 6 cyanoalkyl radical; a CC 6 trifluoroalkyl radical; a C r C 5 haloalkyl radical; a phosphoalkyl radical C r C 6 or a sulfoalkyl radical CC 6;
- R2 et R3, identiques ou différents, représentent un atome d'hydrogène ou d'halogène ; un radical alkyle en C C6 ; un radical aralkyle en C7-C12 ou un radical alcoxy en C C6 ;- R 2 and R 3 , identical or different, represent a hydrogen or halogen atom; a CC 6 alkyl radical; a C 7 -C 12 aralkyl radical or a CC 6 alkoxy radical;
- R4 représente un atome d'hydrogène ou d'halogène ; un radical hydroxyle ; un radical alkyle en ; un radical aralkyle en C7-C12 ; un radical monohydroxyalkyle ; un radical polyhydroxyalkyle en C2-C6 ; un radical nitro ; un radical cyano ; un radical cyanoalkyle en CrC6 ; un radical alcoxy en C,-C6 ; un radical trialkyl(CrC6)silanealkyle en CrC6 ; un radical amido ; un radical carboxyle ; un radical alkylcarbonyle en C.,-C6 ; un radical thio ; un radical thioalkyle en C C6 ; un radical alkyl(C C6)thio ; un radical amino ; un radical amino protégé par un radical alkyl(C C6)carbonyle, carbamyle ou alkyl(C.,- C5)sulfonyle ; ou un groupement NHR" ou NR"R"' dans lesquels R" et R'", identiques ou différents, représentent un radical alkyle en CrC6, un radical monohydroxyalkyle en C,-C6 ou un radical polyhydroxyalkyle en C2-C6 ;- R 4 represents a hydrogen or halogen atom; a hydroxyl radical; an alkyl radical in; a C 7 -C 12 aralkyl radical; a monohydroxyalkyl radical ; a C 2 -C 6 polyhydroxyalkyl radical; a nitro radical; a cyano radical; a C r C 6 cyanoalkyl radical; a C 1 -C 6 alkoxy radical; a trialkyl radical (C r C 6) alkylsilane C r C 6; an amido radical; a carboxyl radical; a C 1 -C 6 alkylcarbonyl radical; a thio radical; a CC 6 thioalkyl radical; an alkyl radical (CC 6 ) thio; an amino radical; an amino radical protected by an alkyl (CC 6 ) carbonyl, carbamyl or alkyl (C., - C 5 ) sulfonyl radical; or an NHR "or NR" R "'group in which R" and R'", identical or different, represent a C r C 6 alkyl radical, a C 6 -C 6 monohydroxyalkyl radical or a C 2 polyhydroxyalkyl radical -C 6 ;
R5 représente un radical alkyle en CrC6 ; un radical monohydroxyalkyle en CrC6 ; un radical polyhydroxyalkyle en C2-C6 ; un radical aralkyle en C7-C12 ; un radical aryle ; un radical aminoalkyle en un radical aminoalkyle en C C6 dont l'aminé est protégée par un radical alkyl(C1-C6)carbonyle. carbamyle ou alkyl(C1-C6)sulfonyle ; un radical carboxyalkyle en C,-Cg ; un radical cyanoalkyle en CrC6 ; un radical carbamylalkyle en C,-C6 ; un radical trifluoroalkyle en C,-C6 ; un radical trialkyl(C C6)silanealkyle en C C6 ; un radical sulfonamidoalkyle en C C6 ; un radical alkyl(C1-C6)carboxyalkyle en CrC6 ; un radical alkyl(C C6)sulfinylalkyle en C C6 ; un radical alkyl(C C6)sulfonylalkyle en C C6 ; un radical alkyl(CrC6)cétoalkyle en CrC6 ; un radical N-alkyl(C1-C6)carbamylalkyle en CrC6 ; un radical N-alkyl(C1-C6)sulfonamidoalkyle en CrC6 ;R 5 represents a C r C 6 alkyl radical; a C r C 6 monohydroxyalkyl radical; a C 2 -C 6 polyhydroxyalkyl radical; a C 7 -C 12 aralkyl radical; a aryl radical; an aminoalkyl radical into a CC 6 aminoalkyl radical, the amine of which is protected by a (C 1 -C 6 ) alkyl carbonyl radical. carbamyl or (C 1 -C 6 ) alkyl sulfonyl; a C 1 -C 6 carboxyalkyl radical; a C r C 6 cyanoalkyl radical; a C 1 -C 6 carbamylalkyl radical; a C 6 -C 6 trifluoroalkyl radical; a trialkyl (CC 6 ) silanealkyl radical in CC 6 ; a CC 6 sulfonamidoalkyl radical; an alkyl (C 1 -C 6) carboxyalkyl, C r C 6; an alkyl radical (CC 6) alkylsulphinyl CC 6; an alkyl radical (CC 6) sulfonylalkyl CC 6; an alkyl (C r -C 6) alkylketo C r C 6; an N-C 1 -C 6 carbamylalkyl C r C 6 radical; an N-C 1 -C 6 sulfonamidoalkyl radical in C r C 6 ;
R6 représente un atome d'hydrogène ou d'halogène ; un radical alkyle en C C6 ; un radical alcoxy en C,-C6 ; un radical acétylamino ; un radical monohydroxyalkyle en C C6 ; un radical polyhydroxyalkyle en C2-C6 ; un radical alcoxy(C C6)alkyle en CrC6 ; un radical thiophène ; un radical furane ; un radical phényle ; ou un radical aralkyle en C C6 ;R 6 represents a hydrogen or halogen atom; a CC 6 alkyl radical; a C 1 -C 6 alkoxy radical; an acetylamino radical; a CC 6 monohydroxyalkyl radical; a C 2 -C 6 polyhydroxyalkyl radical; alkoxy (CC 6) C r C 6; a thiophene radical; a furan radical; a phenyl radical; or a CC 6 aralkyl radical;
- X représente un anion monovalent ou divalent ;- X represents a monovalent or divalent anion;
consistant dans une première étape, à faire réagir dans un solvant contenant au moins une base, un 1 ,5,6,7-tetrahydro-indol-4-one de formule (II) suivante :consisting in a first step, in reacting in a solvent containing at least one base, a 1,5,6,7-tetrahydro-indol-4-one of formula (II) below:
dans lequel R,, R2, R3 et R6 ont les mêmes significations que celles indiquées ci- dessus pour les composés de formule (I), avec une 3-pyridinecarboxaldéhyde de formule (III) suivante : in which R ,, R 2 , R 3 and R 6 have the same meanings as those indicated above for the compounds of formula (I), with a 3-pyridinecarboxaldehyde of formula (III) below:
(III) dans laquelle R4 a les mêmes significations que celles indiquées ci-dessus pour les composés de formule (I), pour obtenir un dérivé d'énone de formule (IV) suivante :(III) in which R 4 has the same meanings as those indicated above for the compounds of formula (I), to obtain an enone derivative of formula (IV) below:
dans lequel R1 t R2, R3, R4 et R6 ont les mêmes significations que celles indiquées ci-dessus pour les composés de formule (I), puis dans une deuxième étape, à faire réagir, en milieu solvant, ledit dérivé d'énone de formule (IV) avec un agent quaternisant R5X dans lequel R5 et X ont les mêmes significations que celles indiquées ci-dessus pour les composés de formule (I), pour obtenir une cyclohexénone de formule (V) suivante :in which R 1 t R 2 , R 3 , R 4 and R 6 have the same meanings as those indicated above for the compounds of formula (I), then in a second step, in reacting, in a solvent medium, said enone derivative of formula (IV) with a quaternizing agent R 5 X in which R 5 and X have the same meanings as those indicated above for the compounds of formula (I), to obtain a cyclohexenone of formula (V) next :
dans laquelle les radicaux R1 à R6 et X ' ont les mêmes significations que celles indiquées ci-dessus pour les composés de formule (I), puis dans une troisième étape, à aromatiser ladite cyclohexénone de formule (V) ainsi obtenue, en milieu solvant et en présence d'une base, pour obtenir le composé de formule (I) attendu.in which the radicals R 1 to R 6 and X ' have the same meanings as those indicated above for the compounds of formula (I), then in a third step, in flavoring said cyclohexenone of formula (V) thus obtained, in a solvent medium and in the presence of a base, to obtain the expected compound of formula (I).
Ce procédé de synthèse conforme à l'invention peut être représenté selon le schéma de synthèse ci-après :This synthesis process in accordance with the invention can be represented according to the synthesis scheme below:
Le procédé de synthèse des 3-(4-hydroxy-1 H-indol-5-ylméthyl)-pyridiniums de formule (I) conforme à l'invention se distingue essentiellement de celui décrit dans l'art antérieur par le fait que les conditions de température et la base utilisée lors de la première étape permettent d'aboutir à un composé de formule (IV), de manière sécurisée, (les bases employées ne nécessitant pas de conditions particulières de manipulations). De plus les composés de formule (I) sont obtenus avec un rendement global supérieur à 45 % alors que le rendement global du procédé antérieur n'était d'environ que de 9 %. Enfin les composés de formule (I) ne nécessitent pas d'étape supplémentaire de purification par chromatographie. comme cela est le cas pour le procédé de l'art antérieur. Ces avantages rendent le procédé de synthèse conforme à l'invention parfaitement transposable sur un plan industriel. Selon le procédé de l'invention, R1 et R5, indépendamment l'un de l'autre, représentent de préférence un radical méthyle, éthyle ou 2-hydroxyéthyle ; R2, R3, R4 et R6 représentent de préférence un atome d'hydrogène ou un radical méthyle.The process for the synthesis of 3- (4-hydroxy-1 H-indol-5-ylmethyl) -pyridiniums of formula (I) according to the invention differs essentially from that described in the prior art by the fact that the conditions of temperature and the base used during the first step make it possible to arrive at a compound of formula (IV), in a secure manner, (the bases used do not require any particular handling conditions). In addition, the compounds of formula (I) are obtained with an overall yield greater than 45% while the overall yield of the prior process was only around 9%. Finally, the compounds of formula (I) do not require an additional purification step by chromatography. as is the case for the method of the prior art. These advantages make the synthesis process according to the invention perfectly transposable on an industrial level. According to the process of the invention, R 1 and R 5 , independently of one another, preferably represent a methyl, ethyl or 2-hydroxyethyl radical; R 2 , R 3 , R 4 and R 6 preferably represent a hydrogen atom or a methyl radical.
Selon l'invention, X " est de préférence choisi parmi un atome d'halogène tel que le chlore, le brome ou l'iode ; un hydroxyde ; un hydrogénosulfate ; un alkylsulfate ou un carboxylate.According to the invention, X " is preferably chosen from a halogen atom such as chlorine, bromine or iodine; a hydroxide; a hydrogen sulphate; an alkyl sulphate or a carboxylate.
Parmi les 3-(4-hydroxy-1 H-indol-5-ylméthyl)-pyridiniums de formule (I) que l'on peut obtenir en mettant en œuvre le procédé de l'invention, on peut notamment citer :Among the 3- (4-hydroxy-1 H-indol-5-ylmethyl) -pyridiniums of formula (I) which can be obtained by implementing the process of the invention, there may be mentioned in particular:
- le méthylsulfate de 3-(4-hydroxy-1-méthyl-1 H-indol-5-ylméthyl)-1 -méthyl- pyridinium ;- 3- (4-hydroxy-1-methyl-1 H-indol-5-ylmethyl) -1-methylpyridinium methylsulfate;
- le chlorure de 3-(4-hydroxy-1-méthyl-1 H-indol-5-ylméthyl)-1-méthyl-pyridinium ; et- 3- (4-hydroxy-1-methyl-1 H-indol-5-ylmethyl) -1-methyl-pyridinium chloride; and
- le chlorure de 3-(4-hydroxy-1-méthyl-1 H-indol-5-ylméthyl)-1-(2-hydroxyéthyl)- pyridinium.- 3- (4-hydroxy-1-methyl-1 H-indol-5-ylmethyl) -1- (2-hydroxyethyl) chloride - pyridinium chloride.
D'une manière avantageuse, le ou les solvants utilisés dans les différentes étapes du procédé conforme à l'invention sont des solvants inertes comme par exemple un alcool inférieur en CrC4 tel que le méthanol, l'éthanol, l'isopropanol ou l'isobutanol ; l'éther éthylique ; le tert-butylméthyléther ; le tetrahydrofurane ; le toluène ; l'hexane ; l'heptane ; l'acétate d'éthyle ; le chloroforme ; le dichlorométhane ou l'acétonitrile ; en présence ou non d'un agent de transfert de phase tel que par exemple un ammonium quaternaire ou un sel d'acide sulfosuccinique. De façon préférentielle, le solvant utilisé est un alcool en C C4 tel que le méthanol, l'éthanol, l'isobutanol ; le tetrahydrofurane ou l'acétate d'éthyle.Advantageously, the solvent or solvents used in the various stages of the process according to the invention are inert solvents such as, for example, a lower C r C 4 alcohol such as methanol, ethanol, isopropanol or isobutanol; ethyl ether; tert-butyl methyl ether; tetrahydrofuran; toluene; hexane; heptane; ethyl acetate; chloroform; dichloromethane or acetonitrile; in the presence or absence of a phase transfer agent such as for example a quaternary ammonium or a salt of sulfosuccinic acid. Preferably, the solvent used is a CC 4 alcohol such as methanol, ethanol, isobutanol; tetrahydrofuran or ethyl acetate.
Le solvant utilisé lors de la première étape est de préférence choisi parmi le méthanol, l'éthanol, le tetrahydrofurane et le toluène. Le solvant utilisé lors de la deuxième étape est de préférence choisi parmi l'acétate d'éthyle et le tetrahydrofurane.The solvent used during the first step is preferably chosen from methanol, ethanol, tetrahydrofuran and toluene. The solvent used during the second step is preferably chosen from ethyl acetate and tetrahydrofuran.
Le solvant utilisé lors de la troisième étape est de préférence choisi parmi l'éthanol, l'isopropanol et l'isobutanol.The solvent used during the third step is preferably chosen from ethanol, isopropanol and isobutanol.
La base utilisée lors de la première étape est de préférence choisie parmi l'hydroxyde de sodium, l'hydroxyde de potassium, et le méthylate de sodium. La quantité de base utilisée est de préférence de l'ordre de deux équivalents molaires par rapport au nombre de mole de composé de formule (II) à faire réagir.The base used during the first step is preferably chosen from sodium hydroxide, potassium hydroxide, and sodium methylate. The amount of base used is preferably of the order of two molar equivalents relative to the number of moles of compound of formula (II) to be reacted.
La base utilisée lors de la troisième étape est de préférence choisie parmi la triéthylamine et la pipéridine. La quantité de base utilisée est de préférence de l'ordre de deux équivalents et demi par rapport au nombre de mole de composé de formule (V) à faire réagir.The base used during the third step is preferably chosen from triethylamine and piperidine. The amount of base used is preferably of the order of two and a half equivalents relative to the number of moles of compound of formula (V) to be reacted.
L'agent quatemisant utilisé lors de la deuxième étape est de préférence choisi parmi le diméthylsulfate et le chlorométhane.The quaternizing agent used during the second step is preferably chosen from dimethyl sulphate and chloromethane.
Selon une forme de réalisation avantageuse du procédé de l'invention, la température de la réaction lors de la première étape est comprise entre 0 et 60°C environ et de préférence entre 20 et 30°C environ. Une température tout particulièrement préférée se situe aux environs de 25°C.According to an advantageous embodiment of the process of the invention, the reaction temperature during the first step is between 0 and 60 ° C approximately and preferably between 20 and 30 ° C approximately. A particularly preferred temperature is around 25 ° C.
Bien entendu, lors de la première étape, et en fonction de la nature des différents radicaux présents sur le composé de formule (II) de départ, l'homme de l'art veillera à protéger certains substituants pour que ceux-ci n'interviennent pas dans la suite des réactions. Ainsi, et à titre d'exemple, lorsqu'un composé de formule (II) dans lequel R4 représente un radical hydroxyle est utilisé, il conviendra alors de protéger ledit radical hydroxyle à l'aide d'un groupement protecteur en formant l'éther benzilique correspondant. Lorsque la réaction est terminée, les produits attendus, tels que par exemple le méthylsulfate de 3-(4-hydroxy-1 -méthyl-1 H-indol-5-ylméthyl)-1 -méthyl-pyridinium, peuvent, le cas échéant, être récupérés par des méthodes bien connues de l'état de la technique telles que la filtration ou cristallisation.Of course, during the first step, and depending on the nature of the different radicals present on the starting compound of formula (II), those skilled in the art will take care to protect certain substituents so that they do not intervene not in the continuation of the reactions. Thus, and by way of example, when a compound of formula (II) in which R 4 represents a hydroxyl radical is used, it will then be necessary to protect said hydroxyl radical with the aid of a protective group by forming the corresponding benzil ether. When the reaction is complete, the expected products, such as for example 3- (4-hydroxy-1-methyl-1H-indol-5-ylmethyl) -1-methyl-pyridinium methyl sulfate, may, if necessary, be recovered by methods well known in the state of the art such as filtration or crystallization.
Les composés de formule (I) obtenus selon le procédé conforme à l'invention peuvent être utilisés comme produits finis dans tout type d'industrie comme l'industrie cosmétique, notamment à titre de coupleur pour la teinture d'oxydation des fibres kératiniques.The compounds of formula (I) obtained according to the process in accordance with the invention can be used as finished products in any type of industry such as the cosmetic industry, in particular as a coupler for the oxidation dyeing of keratin fibers.
Les dérivés d'énone de formule (IV) et (V) formés respectivement à la fin de la première étape et de la deuxième étape du procédé de synthèse conforme à l'invention sont des composés nouveaux, et à ce titre, constituent un autre objet de l'invention.The enone derivatives of formula (IV) and (V) formed respectively at the end of the first stage and of the second stage of the synthesis process in accordance with the invention are new compounds, and as such constitute another subject of the invention.
Parmi ces dérivés d'énone de formule (IV) et (V) on peut notamment citer :Among these enone derivatives of formula (IV) and (V) there may be mentioned in particular:
- le 1-méthyl-5-pyridin-3-ylméthylène-1 ,5,6,7-tetrahydro-indol-4-one ;- 1-methyl-5-pyridin-3-ylmethylene-1, 5,6,7-tetrahydro-indol-4-one;
- le méthylsulfate de 1 -méthyl-3-(1-méthyl-4-oxo-1 ,4,6,7-tetrahydro-indol-5- ylidèneméthyl)-pyridinium ; - le chlorure de 1-méthyl-3-(1-méthyl-4-oxo-1 ,4,6,7-tetrahydro-indol-5- ylidèneméthyl)-pyridinium ; et- 1-methyl-3- (1-methyl-4-oxo-1,4,6,7-tetrahydro-indol-5-ylidenemethyl) -pyridinium methyl sulfate; - 1-methyl-3- (1-methyl-4-oxo-1, 4,6,7-tetrahydro-indol-5-ylidenemethyl) -pyridinium chloride; and
- le chlorure de 1-(2-hydroxyéthyl)-3-(1 -méthyl-4-oxo-1 ,4,6,7-tetrahydro-indol-5- ylidèneméthyl)-pyridinium.- 1- (2-hydroxyethyl) -3- (1-methyl-4-oxo-1, 4,6,7-tetrahydro-indol-5-ylidenemethyl) -pyridinium chloride.
Ces nouveaux dérivés d'énone de formules (IV) et (V) peuvent bien entendu être utilisés dans tout type d'industrie, chimique, cosmétique, alimentaire, pharmaceutique ou autre. Ils peuvent notamment être utilisés à titre de composés intermédiaires dans la synthèse des composés de formule (I) tels définis précédemment.These new enone derivatives of formulas (IV) and (V) can of course be used in any type of industry, chemical, cosmetic, food, pharmaceutical or other. They can in particular be used as intermediate compounds in the synthesis of the compounds of formula (I) as defined above.
L'exemple de préparation qui suit est destiné à illustrer l'invention. EXEMPLESThe example of preparation which follows is intended to illustrate the invention. EXAMPLES
EXEMPLE 1 : Synthèse du méthylsulfate de 3-(4-hydroxy-1 -méthyl-1 H-indol- 5-ylméthyl)-1 -méthyl-pyridiniumEXAMPLE 1 Synthesis of 3- (4-hydroxy-1-methyl-1 H-indol-5-ylmethyl) -1-methyl-pyridinium methyl sulfate
a) Etape n° 1 : Préparation du 1-méthyl-5-pyridin-3-ylméthylène-1 , 5,6,7- tetrahvdro-indol-4-onea) Step 1: Preparation of 1-methyl-5-pyridin-3-ylmethylene-1, 5,6,7- tetrahvdro-indol-4-one
Dans un ballon de 250 ml, on a dissous 4,5 g de 1-méthyl-1 ,5,6;7-tetrahydro- indol-4-one (0,03 mole) et 9,8 g de pyridine-3-carboxaldéhyde (0,09 mole) dans 15 ml de toluène. On a ensuite ajouté au milieu réactionnel 11 ml d'une solution de méthylate de sodium dans du méthanol à 30% (0,06 mole) en refroidissant à l'aide d'un bain de glace/eau. On a agité le milieu réactionnel à 25 °C pendant 4 heures. Le milieu réactionnel a ensuite été évaporé sous vide presque à sec. Le résidu obtenu a été mélangé avec 30 ml d'eau, puis refroidi à 4°C pendant 1 heure. Le solide obtenu a ensuite été rincé par 2 fois 20 ml d'eau. Après séchage, on a obtenu 4,6 g d'une poudre blanche avec un rendement de 64 % et dont le point de fusion (Kofler) était de 159 °C. L'analyse RMN-1H (CDCI3, 200 MHz) conforme au produit attendu était la suivante :In a 250 ml flask, 4.5 g of 1-methyl-1,5,6; 7-tetrahydro-indol-4-one (0.03 mole) and 9.8 g of pyridine-3- were dissolved. carboxaldehyde (0.09 mole) in 15 ml of toluene. 11 ml of a solution of sodium methoxide in 30% methanol (0.06 mol) were then added to the reaction medium, while cooling using an ice / water bath. The reaction medium was stirred at 25 ° C for 4 hours. The reaction medium was then evaporated under vacuum almost to dryness. The residue obtained was mixed with 30 ml of water, then cooled to 4 ° C for 1 hour. The solid obtained was then rinsed with 2 times 20 ml of water. After drying, 4.6 g of a white powder were obtained with a yield of 64% and whose melting point (Kofler) was 159 ° C. 1 H NMR analysis (CDCI 3 , 200 MHz) in accordance with the expected product was as follows:
8,49 (d, J = 2Hz, 1 H) ; 8,39 (dd, J = 2,5 Hz, 1 H) ; 7,5 (m, 2H) ;8.49 (d, J = 2Hz, 1H); 8.39 (dd, J = 2.5 Hz, 1 H); 7.5 (m, 2H);
7,19 (dd, J = 5,8Hz, 1 H) ; 6,51 (d, J = 3Hz, 1 H) ; 6,46 (d, J = 3 Hz, 1 H) ;7.19 (dd, J = 5.8 Hz, 1 H); 6.51 (d, J = 3 Hz, 1 H); 6.46 (d, J = 3 Hz, 1 H);
3,44 (s, 3H) ; 2,95 (t, J = 6Hz, 2H) ; 2,68 (t, J = 6Hz, 2H). b) Etape n°2 : Préparation du méthylsulfate de 1-méthyl-3-(1 -méthyl-4-oxo- 1 ,4,6,7-tetrahvdro-indol-5-ylidèneméthyl)-pyridinium3.44 (s, 3H); 2.95 (t, J = 6Hz, 2H); 2.68 (t, J = 6Hz, 2H). b) Step 2: Preparation of 1-methyl-3- (1-methyl-4-oxo-1, 4,6,7-tetrahvdro-indol-5-ylidenemethyl) -pyridinium methyl sulfate
10 g de 1 -méthyl-5-pyridin-3-ylméthylène-1 ,5,6,7-tetrahydro-indol-one (42 mmole) obtenu selon le protocole décrit à l'étape précédente ont été mis en suspension dans 100 ml d'acétate d'éthyle. On a ensuite ajouté 4,5 ml, (47,3 mmole) de sulfate de diméthyle de densité d = 1 ,325. Le mélange hétérogène a été chauffé au reflux pendant 2 heures puis refroidi à température ambiante. Le solide jaune obtenu a été filtré, rincé trois fois avec 30 ml d'acétate d'éthyle. On a obtenu 15,1 g de produit attendu avec un rendement de 99%, et dont le point de fusion (Kofler) était de 170°C. L'analyse RMN-1H (DMSO, 200MHz) conforme au produit attendu était la suivante :10 g of 1-methyl-5-pyridin-3-ylmethylene-1, 5,6,7-tetrahydro-indol-one (42 mmol) obtained according to the protocol described in the previous step were suspended in 100 ml ethyl acetate. Then 4.5 ml (47.3 mmol) of dimethyl sulfate with a density d = 1.325 was added. The heterogeneous mixture was heated at reflux for 2 hours and then cooled to room temperature. The yellow solid obtained was filtered, rinsed three times with 30 ml of ethyl acetate. 15.1 g of expected product were obtained with a yield of 99%, and whose melting point (Kofler) was 170 ° C. 1 H NMR analysis (DMSO, 200 MHz) in accordance with the expected product was as follows:
9,21 (s, 1 H) ; 9,01 (d, J = 6Hz, 1 H) ; 8,70 (d, J = 8Hz, 1 H) ; 8,24 (dd, 8Hz, 1 H) ; 7,55 (s, 1 H) ; 6,96 (d, J = 3Hz, 1 H) ;9.21 (s, 1H); 9.01 (d, J = 6Hz, 1H); 8.70 (d, J = 8Hz, 1H); 8.24 (dd, 8Hz, 1H); 7.55 (s, 1H); 6.96 (d, J = 3 Hz, 1 H);
6,50 (d, J = 3Hz, 1 H) ; 4,45 (s, 3H) ; 3,80 (s, 3H) ; 3,45 (s, 3H) ; 3,13 (t, J = 6Hz, 2H) ; 2,97 (t, J = 6Hz, 2H).6.50 (d, J = 3 Hz, 1 H); 4.45 (s, 3H); 3.80 (s, 3H); 3.45 (s, 3H); 3.13 (t, J = 6Hz, 2H); 2.97 (t, J = 6Hz, 2H).
c) Etape n°3 : Préparation du méthylsulfate de 3-(4-hvdroxy-1-méthyl-1 H-indol-5- ylméthyl)-1 -méthyl-pyridiniumc) Step 3: Preparation of 3- (4-hvdroxy-1-methyl-1 H-indol-5-ylmethyl) -1-methyl-pyridinium methyl sulfate
Dans un ballon de 250 ml, on a introduit 12,0 g (33mmole) de méthylsulfate de 1- méthyl-3-(1-méthyl-4-oxo-1 ,4,6,7-tetrahydro-indol-5-ylidèneméthyl)-pyridinium obtenu ci-dessus à l'étape précédente et 90 ml d'éthanol absolu. On a chauffé sous azote au reflux pour obtenir une solution homogène. On a ensuite ajouté 12 ml (86 mmole) de triéthylamine de densité d = 0,726. On a continué à chauffer le mélange réactionnel au reflux pendant environ 16 heures. Le milieu réactionnel a ensuite été refroidi à température ambiante. Le solide obtenu a été filtré, puis rincé trois fois avec 30 ml d'éthanol absolu. On a obtenu, avec un rendement de 82,5%, 9,9 g du produit attendu sous la forme d'un solide jaune foncé qui a fondu 215 °C (Kofler). L'analyse RMN-1H conforme au produit attendu était la suivante : ,25 (s, 1H);8,96(s, 1H) ; 8,84 (d, J = 6HZ, 1H) ; 8,40 (d, J = 8HZ, 1H); ,06 (dd, J = 6, 8Hz, 1H) ; 7,21 (d, J = 3Hz, 1H) ; 7,08 (d, J = 7 Hz, 1 H) ; ,94 (d, J = 7Hz, 1 H) ; 6,70 (d, J = 3Hz, 1H) ; 4,38 (s, 3H) ; 4,22 (s, 2H) ; ,77 (s, 3H) ; 3,44 (s, 3H). 12.0 g (33mmol) of 1-methyl-3- (1-methyl-4-oxo-1, 4,6,7-tetrahydro-indol-5-ylidenemethyl) methyl sulfate are introduced into a 250 ml flask ) -pyridinium obtained above in the previous step and 90 ml of absolute ethanol. It was heated under nitrogen at reflux to obtain a homogeneous solution. 12 ml (86 mmol) of triethylamine with a density d = 0.726 were then added. The reaction mixture was continued to reflux for about 16 hours. The reaction medium was then cooled to room temperature. The solid obtained was filtered, then rinsed three times with 30 ml of absolute ethanol. There was obtained, with a yield of 82.5%, 9.9 g of the expected product in the form of a dark yellow solid which melted 215 ° C (Kofler). The 1 H NMR analysis in accordance with the expected product was as follows: , 25 (s, 1H); 8.96 (s, 1H); 8.84 (d, J = 6HZ, 1H); 8.40 (d, J = 8HZ, 1H); .06 (dd, J = 6.8Hz, 1H); 7.21 (d, J = 3Hz, 1H); 7.08 (d, J = 7 Hz, 1 H); , 94 (d, J = 7 Hz, 1 H); 6.70 (d, J = 3Hz, 1H); 4.38 (s, 3H); 4.22 (s, 2H); , 77 (s, 3H); 3.44 (s, 3H).
Claims
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU44252/01A AU4425201A (en) | 2000-03-24 | 2001-03-15 | Method for preparing 3-(4-hydroxy-1h-indol-5-ylmethyl)-pyridinium compounds via enones |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR00/03792 | 2000-03-24 | ||
| FR0003792A FR2806721B1 (en) | 2000-03-24 | 2000-03-24 | PROCESS FOR THE PREPARATION OF COMPOUNDS 3- (4-HYDROXY-1H-UNDOL-5- YLMETHYL) -PYRIDINIUMS PASSING THROUGH ENONES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2001072739A1 true WO2001072739A1 (en) | 2001-10-04 |
Family
ID=8848484
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/FR2001/000778 Ceased WO2001072739A1 (en) | 2000-03-24 | 2001-03-15 | Method for preparing 3-(4-hydroxy-1h-indol-5-ylmethyl)-pyridinium compounds via enones |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU4425201A (en) |
| FR (1) | FR2806721B1 (en) |
| WO (1) | WO2001072739A1 (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB925429A (en) * | 1960-04-01 | 1963-05-08 | Irwin Neisler & Co | Indole derivatives |
| EP0377450A1 (en) * | 1989-01-05 | 1990-07-11 | The Du Pont Merck Pharmaceutical Company | Substituted indole, benzofuran and benzothiophene derivatives as 5-lipoxygenase inhibitors |
| EP0692473A1 (en) * | 1994-07-12 | 1996-01-17 | Minnesota Mining And Manufacturing Company | Process for preparing carbamoyl pyridinium compounds |
| FR2783520A1 (en) * | 1998-09-21 | 2000-03-24 | Oreal | NEW CATIONIC 4-HYDROXYINDOLES, THEIR USE FOR THE OXIDIZING DYE OF KERATINIC FIBERS, TINCTORIAL COMPOSITIONS AND DYING PROCESS |
-
2000
- 2000-03-24 FR FR0003792A patent/FR2806721B1/en not_active Expired - Fee Related
-
2001
- 2001-03-15 AU AU44252/01A patent/AU4425201A/en not_active Abandoned
- 2001-03-15 WO PCT/FR2001/000778 patent/WO2001072739A1/en not_active Ceased
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB925429A (en) * | 1960-04-01 | 1963-05-08 | Irwin Neisler & Co | Indole derivatives |
| EP0377450A1 (en) * | 1989-01-05 | 1990-07-11 | The Du Pont Merck Pharmaceutical Company | Substituted indole, benzofuran and benzothiophene derivatives as 5-lipoxygenase inhibitors |
| EP0692473A1 (en) * | 1994-07-12 | 1996-01-17 | Minnesota Mining And Manufacturing Company | Process for preparing carbamoyl pyridinium compounds |
| FR2783520A1 (en) * | 1998-09-21 | 2000-03-24 | Oreal | NEW CATIONIC 4-HYDROXYINDOLES, THEIR USE FOR THE OXIDIZING DYE OF KERATINIC FIBERS, TINCTORIAL COMPOSITIONS AND DYING PROCESS |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2806721A1 (en) | 2001-09-28 |
| AU4425201A (en) | 2001-10-08 |
| FR2806721B1 (en) | 2002-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0576350B1 (en) | Branched alkylamino thiazole derivatives, process for their preparation and pharmaceutical compositions containing them | |
| JP3121061B2 (en) | Method for producing intermediate for producing alkoxyiminoacetamides and intermediate used therein | |
| EP0566468B1 (en) | Process for the preparation of a biphenyl derivative | |
| LU85245A1 (en) | NOVEL AZOLIC COMPOUNDS, THEIR PREPARATION AND THEIR USE AS ANTIFUNGALS AND FUNGICIDES | |
| EP0550313A1 (en) | 2-(Tetranol-5-yl)-(1,1'-biphenyl)derivatives, their preparation and use as intermediates | |
| LU85551A1 (en) | NOVEL AZOLIC COMPOUNDS, THEIR PREPARATION AND THEIR USE AS ANTIFUNGALS AND FUNGICIDES | |
| CH646967A5 (en) | PYRANONE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME. | |
| JPH02207083A (en) | Production of 2-nitroiminoimidazolidines | |
| EP0110755A1 (en) | Piperidine dione derivatives with a myocardium protecting and antiarrhytmic activity, process for their preparation and medicines containing them | |
| EP0374041B1 (en) | Medicaments containing 2-benzothiazolamine derivatives, compounds and their preparation | |
| FR2479821A1 (en) | N4-CARBAMOYLPIPERAZINOPROPANOL DERIVATIVES USEFUL FOR THEIR ADRENALINE B-BLOCKING ACTIVITY | |
| CA1229603A (en) | 1h,3h-pyrrolo ¬1,2-c| thiazole derivatives; process for preparing the same and pharmaceutical compositions containing these derivatives | |
| FR2597475A1 (en) | USE OF AROMATIC AND HETEROCYCLIC AMINES AS MEDICAMENTS AND AGROCHEMICAL PRODUCTS. | |
| EP0002978B1 (en) | Thiazolidinedione-2,4 derivatives, their preparation and pharmaceutical applications | |
| EP0070231A1 (en) | Synthesis of 3,4-diphenyl-5-methylpyrazole derivatives | |
| CA2337270C (en) | Method for preparing 4-(3-pyridinyl)-1h-imidazole and the intermediates used | |
| WO2001072739A1 (en) | Method for preparing 3-(4-hydroxy-1h-indol-5-ylmethyl)-pyridinium compounds via enones | |
| FR2862965A1 (en) | NOVEL PHENOXYACETAMIDE DERIVATIVES AND THEIR USE FOR THE PREPARATION OF DIPHENYLAMIDES. | |
| WO2001074803A1 (en) | Method for preparing 3-(4-hydroxy-1h-indol-ylmethyl)-pyridinium compounds using an aldolisation reaction | |
| EP0656884A1 (en) | Novel poly-iodated compounds, method of preparation and contrast product containing same | |
| FR2811988A1 (en) | PROCESS FOR THE PREPARATION OF 3 - (- 4-HYDROXY-1H-INDOL-5- YLMETHYL) -PYRIDINIUM COMPOUNDS WHICH DO NOT USE 3- PYRIDINECARBOXALDEHYDES | |
| FR2587333A1 (en) | NOVEL BICYCLIC ALLYLIC ETHERS, THEIR PREPARATION AND THEIR USE AS ANTI-FUNGICIDES AND FUNGICIDES | |
| FR2707989A1 (en) | Novel silylated benzylamine derivatives, their salts, processes for their manufacture and pharmaceutical compositions containing them. | |
| EP0412014A1 (en) | Benzothiazine derivatives, their preparation and their uses as medicines or as intermediates for the synthesis of medicines | |
| BE858864A (en) | NEW ESTERS OF PHENYL- AND PYRIDINE-3-CARBOXYLIC ACIDS AND PROCESS FOR THEIR PREPARATION |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| NENP | Non-entry into the national phase |
Ref country code: JP |